drug developer News
Most Popular drug developer Story
Daiichi Sankyo acquires Ranbaxy in $4.6B deal
Ranbaxy's drive to become a research-based drug developer and major manufacturer has led it straight into the Read more...
Latest Headlines
- August 16, 2011
- January 15, 2010
- June 11, 2008
- April 18, 2008
- April 17, 2008
- April 16, 2008
- March 25, 2008
- March 6, 2008
- February 20, 2008
- February 11, 2008
- February 11, 2008
- February 6, 2008
- February 4, 2008
- January 31, 2008
- January 28, 2008
- January 17, 2008
- January 10, 2008
- December 21, 2007
- December 14, 2007
- December 6, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
